Renal Tubulopathies and related disorders
Gene: CYP11B2EnsemblGeneIds (GRCh38): ENSG00000179142
EnsemblGeneIds (GRCh37): ENSG00000179142
OMIM: 124080, Gene2Phenotype
CYP11B2 is in 7 panels
1 review
Paul De Fazio (Victorian Clinical Genetics Services)
Multiple (>>3) unrelated individuals reported with hypoaldosteronism due to corticosterone methyloxidase type I or II deficiency.
CYP11B2 catalyses both the penultimate and ultimate steps in aldosterone biosynthesis. Variants affecting the penultimate step cause CMO I deficiency, while variants affecting only or predominantly the ultimate step cause CMO II deficiency, and the two overlap phenotypically but have distinct biochemical features (PMID:8772616, 9814506).Created: 21 Sep 2020, 6:49 a.m. | Last Modified: 21 Sep 2020, 6:49 a.m.
Panel Version: 0.15
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600).
Publications
Variants in this GENE are reported as part of current diagnostic practice
Details
- Mode of Inheritance
- BIALLELIC, autosomal or pseudoautosomal
- Sources
-
- Expert Review Green
- KidGen_AldoHypertension v38.1.0
- Phenotypes
-
- Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600)
- OMIM
- 124080
- Clinvar variants
- Variants in CYP11B2
- Penetrance
- None
- Publications
- Panels with this gene
History Filter Activity
Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)gene: CYP11B2 was added gene: CYP11B2 was added to Renal Tubulopathies and related disorders. Sources: KidGen_AldoHypertension v38.1.0,Expert Review Green Mode of inheritance for gene: CYP11B2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CYP11B2 were set to 9360501; 9814506; 12788848; 8439335; 8772616; 15240589 Phenotypes for gene: CYP11B2 were set to Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600)